Superdisintegrants Market

Superdisintegrants Market by Product (Modified Starch, Modified Cellulose, Crospovidone, Ion Exchange Resin), Formulation (Tablet, Capsules), Therapeutic Area (Gastrointestinal, Cardiovascular, Neurology, Oncology, Hematology) - Global Forecast to 2023

Report Code: PH 4350 Aug, 2018, by marketsandmarkets.com

[182 Pages Report] The overall superdisintegrants market is expected to grow from USD 341.1 million in 2017 to USD 536.5 million by 2023, at a CAGR of 7.9% during the forecast period of 2018 to 2023. Excipients are integral nontherapeutic substances used for the designing and development of drugs from active molecules which cannot be administered in the pure form. The use of excipients helps achieve better patient compliance, dose accuracy, and consistency. Superdisintegrants play an important role in reducing the disintegration time of oral solid dosage forms such as tablets and capsules, thereby improving their efficiency. Due to this advantage of superdisintegrants, these are heavily used during the formation of orally or fast disintegrating oral formulations, which, in turn, propel the growth of this market. These superdisintegrants are being used in various oral dosage forms which are further used in the treatment of neurological diseases, gastrointestinal disease, oncology, inflammatory diseases, infectious diseases, cardiovascular diseases, and hematological diseases. The base year considered for the study is 2017, and the forecast has been provided for the period between 2018 and 2023.

Market Dynamics

Superdisintegrants Market

The rising demand for the innovative and effective therapies in the treatment of neurological diseases drives the global superdisintegrants market

Neurological or neurodegenerative diseases are a heterogeneous group of disorders characterized by the progressive degeneration of the structure and function of the CNS or peripheral nervous system. The WHO (2018) reported that various types of neurological disorders affect millions of people around the world, including 24 million that suffer from Alzheimer’s disease and 326 million experience migraines. According to a global study conducted by the WHO, 8 out of 10 disorders in the 3 highest disability classes are neurological. According to the WHO, neurological disorders are one of the leading causes of mortality, accounting for 11.84% of the total deaths globally, in 2015; this number is estimated to increase to 12.22% by 2030. This increasing burden of neurological disorders resulted into increasing demand for the effective and innovative therapies for the treatment of neurological diseases. In order to cater this demand, there is high usage of superdisintegrants in the formulation of orally disintegrating tablets (ODTs) for antidepressants, antipsychotics, antimigraine, and sedatives used in the treatment of neurological conditions is observed in the recent years, which, in turns, drive the growth of this market.

Superdisintegrants Market

The following are the major objectives of the study.

  • To define, describe, segment, and forecast the global superdisintegrants market by product, formulation, therapeutic area, and region
  • To provide detailed information about factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)
  • To analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the superdisintegrants market in five main regions North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa (along with major countries)
  • To profile key players in the global superdisintegrants market and comprehensively analyze their core competencies2 and market shares
  • To track and analyze competitive developments such as mergers and acquisitions; new product/technology launches; expansions; collaborations and agreements; and R&D activities of the leading players in the global superdisintegrants market

During this research study, major players operating in the superdisintegrants market in various regions have been identified, and their offerings, regional presence, and distribution channels have been analyzed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Factiva, along with primary respondents. The entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) pertaining to the market. The figure below shows the breakdown of the primaries on the basis of the company type, designation, and region considered during the research study.

Superdisintegrants Market

To know about the assumptions considered for the study, download the pdf brochure

The superdisintegrants market comprises a network of players involved in the research and product development; raw material supply; manufacturing; distribution and sale. Key players considered in the analysis of the superdisintegrants market are BASF SE (Germany), Ashland Global Holdings Inc. (US), Dowdupont Inc. (US), Roquette Freres (France), DFE Pharma (Germany), JRS Pharma (Germany), Asahi Kasei Corporation (Japan), Merck KGAA (Germany), and Corel Pharma Chem (India).

Major Market Developments

  • In March 2017, BASF Group opened the ‘Innovation Campus Asia Pacific’ in India. The company invested USD 61.6 million (EUR 50 million) in this center to increase its global and regional research activities.
  • In September 2017, the Dow Chemical Company (US) merged with DuPont (US). The combined entity will operate as a holding company under the name DowDuPont.
  • In September 2017, Roquette acquired Itacel, the excipient division of Blanver in Brazil. This will aid the expansion of Roquette’s pharmaceutical excipients business in the Latin American and North American region due to Itacel’s market position in these regions.
  • In October 2016, Ashland opened a new pharmaceutical excipient facility in Nanjing, China, to produce excipients for the Asian market.

Target Audience

  • Superdisintegrants manufacturers
  • Superdisintegrants distributors
  • Pharmaceutical and biotechnology companies
  • Research institutes and academic centers
  • Contract research organizations (CROs)
  • Government associations
  • Market research and consulting firms
  • Venture capitalists and investors

Report Scope

By Type:

  • Natural Superdisintegrants
  • Synthetic Superdisintegrants
    • Modified Starch
    • Modified Cellulose
      • Croscarmellose- Cellulose
      • Low-substituted Hydroxypropyl Cellulose (L-HPC)
    • Crospovidone
    • Ion Exchange Resins
    • Calcium Silicates
  • Other Superdisintegrants

By Formulation:

  • Tablets
  • Capsules

By Therapeutic Area:

  • Gastrointestinal Diseases
  • Neurological Diseases
  • Oncology
  • Infectious Diseases
  • Cardiovascular Diseases
  • Hematological Diseases
  • Inflammatory Diseases

By Region

  • North America: US, Canada
  • Europe: France, Switzerland, Germany, UK, Italy, Spain, Rest of Europe
  • Asia Pacific (APAC): Japan, China, India, Rest of Asia Pacific
  • Latin America
  • Middle East and Africa

Critical questions which the report answers

  • What are the new technologies which the superdisintegrant manufacturers are exploring for the development of the special blends of the superdisintegrants?
  • Which are the key players in the market and how intense is the competition?

Available Customizations

Based on the given market data, MarketsandMarkets offers customizations in the reports as per the client’s specific requirements. The available customization options are as follows:

Geographic Analysis

  • Further breakdown of the Rest of Asia Pacific superdisintegrants market into South Korea, Australia, New Zealand, and other countries
  • Further breakdown of the Latin American superdisintegrants market into Brazil, Mexico, and other countries

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)

The global superdisintegrants market is projected to reach USD 536.5 million by 2023 from USD 366.4 billion in 2018, at a CAGR of 7.9%. Factors contributing to the growth of this market include the increasing adoption of orally disintegrating tablets, growing generics market, and the emergence of new superdisintegrants for the pharmaceutical industry. The shifting focus of pharmaceutical manufacturing to emerging markets and the growth of the overall pharmaceutical sector in these markets present significant opportunities for the superdisintegrants market growth.

The report analyzes the global superdisintegrants market by type, formulation, therapeutic area, and region. By type, the synthetic superdisintegrants segment accounted for the largest share of the market in 2017. The large share of this segment can be attributed to the extensive consumption of these superdisintegrants in various pharmaceutical drug formulations due to the advantages offered such as effectiveness at lower concentrations as compared to starch and a lesser effect on the compressibility and flowability of the dosage form.

Based on formulation, the tablets segment accounted for the larger share of the global superdisintegrants market in 2017. The large share of this segment can be attributed to tablets being the most widely used dosage forms due to the benefits offered such as stability, low manufacturing cost (as compared to other dosage forms), easy product identification, and compactness, along with the increasing focus on orally disintegrating tablets and fast-dissolving tablets.

Based on therapeutic area, the neurological diseases segment is expected to register the highest CAGR during the forecast period. This can be attributed to the increasing incidences of neurological disorders at the global level along with the growing demand for effective therapies.

Geographically, the global superdisintegrants market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2017, Europe accounted for the largest share of the superdisintegrants market, followed by North America and Asia Pacific. The dominance of the European region can be attributed to the presence of a number of pharmaceutical giants with large production capacities leading to extensive consumption of excipients. The growing emphasis on superior pharmaceutical products and generics is also expected to aid the market growth in the region.

Superdisintegrants Market

Rising burden of diseases such as neurological diseases, gastrointestinal diseases, and oncology; and increasing demand for the innovative and effective therapies are driving factors of the superdisintegrants market

Neurological diseases

In 2017, neurological diseases dominated the superdisintegrants market, by therapeutic area. Neurological or neurodegenerative diseases are a heterogeneous group of disorders characterized by the progressive degeneration of the structure and function of the CNS or peripheral nervous system. The WHO (2018) reported that various types of neurological disorders affect millions of people around the world, including 24 million that suffer from Alzheimer’s disease and 326 million experience migraines. Also, according to PhRMA (2018), nearly 100 million individuals have been affected by some kind of neurological disorder in the US alone. According to a global study conducted by the WHO, 8 out of 10 disorders in the 3 highest disability classes are neurological. According to the WHO, neurological disorders are one of the leading causes of mortality, accounting for 11.84% of the total deaths globally, in 2015; this number is estimated to increase to 12.22% by 2030.

Gastrointestinal diseases

As per the International Foundation for Functional Gastrointestinal Disorders, one in every four people in the US suffers from functional GI disorders, with symptoms such as nausea, vomiting, abdominal pain, decreased appetite, early satiety, bloating, swallowing difficulties, and heartburn and/or incontinence. It also states that GI diseases are also becoming common in the developing APAC region, with GERD, IBD, and ulcerative colitis (UC) being the most common.

ODTs with superdisintegrants find high applications in GI disease treatment. The use of superdisintegrants in oral solid formulations for GI diseases have helped overcome problems such as impaired or delayed absorption of APIs in patients suffering from severe gastroparesis and other GI disorders, nausea and vomiting during drug administration, and the difficulty of swallowing in patients with dysphagia. More rapid and high absorption of drugs from the pre-gastric parts of the GI tract improves the bioavailability and efficacy of the drug. Owing to this, the demand for superdisintegrants in this area is expected to increase.

Critical questions the report answers:

  • What are all the developments taking place in the superdisintegrants market in coming years?
  • What are the major therapeutic areas, which are targeted by the superdisintegrants manufacturers?

The prominent players in the global superdisintegrants market are Ashland Inc. (US), BASF SE (Germany), DowDuPont (US), JRS Pharma (Germany), DFE Pharma (Germany), Roquette (France), Asahi Kasei Corporation (Japan), Merck KGaA (Germany), Corel Pharma Chem (India), and Avantor Performance Materials, LLC (US). These players are increasingly undertaking mergers and acquisitions, and product launches to develop and introduce new technologies and products in the market.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 18)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Stakeholders
    1.6 Limitations

2 Research Methodology (Page No. - 22)
    2.1 Research Approach
           2.1.1 Secondary Research
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Research
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Break Down of Primaries
                    2.1.2.3 Key Industry Insights
    2.2 Market Size Estimation
    2.3 Data Triangulation Approach
    2.4 Market Share Estimation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 30)

4 Premium Insights (Page No. - 35)
    4.1 Superdisintegrants Market Overview
    4.2 Superdisintegrants Market: Geographic Growth Opportunities
    4.3 Regional Mix: Superdisintegrants Market (2018–2023)
    4.4 Synthetic Superdisintegrants Market, By Type and Region (2017)
    4.5 Superdisintegrants Market: Developed vs Developing Markets, 2018 vs 2023

5 Market Overview (Page No. - 40)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Market Drivers
                    5.2.1.1 Growing Adoption of Orally Disintegrating Tablets
                    5.2.1.2 Growing Generics Market
                    5.2.1.3 Emergence of New Superdisintegrants for the Pharmaceutical Industry
           5.2.2 Market Opportunities
                    5.2.2.1 Pharmaceutical Market Expansion in Emerging Countries
           5.2.3 Market Challenges
                    5.2.3.1 Safety and Quality Concerns

6 Regulatory Analysis (Page No. - 46)
    6.1 Introduction
    6.2 North America
           6.2.1 US
           6.2.2 Canada
    6.3 Europe
    6.4 Asia Pacific
           6.4.1 Japan
           6.4.2 China
           6.4.3 India

7 Superdisintegrants Market, By Type (Page No. - 52)
    7.1 Introduction
    7.2 Synthetic Superdisintegrants
           7.2.1 Crospovidone
           7.2.2 Modified Starch (Sodium Starch Glycolate)
           7.2.3 Modified Cellulose
                    7.2.3.1 Croscarmellose Sodium
                    7.2.3.2 Low-Substituted Hydroxypropyl Cellulose
           7.2.4 Calcium Silicates
           7.2.5 Ion Exchange Resins
    7.3 Natural Superdisintegrants
    7.4 Other Superdisintegrants

8 Superdisintegrants Market, By Formulation (Page No. - 66)
    8.1 Introduction
    8.2 Tablets
    8.3 Capsules

9 Superdisintegrants Market, By Therapeutic Area (Page No. - 71)
    9.1 Introduction
    9.2 Neurological Diseases
    9.3 Gastrointestinal Diseases
    9.4 Oncology
    9.5 Inflammatory Diseases
    9.6 Infectious Diseases
    9.7 Cardiovascular Diseases
    9.8 Hematological Diseases

10 Superdisintegrants Market, By Region (Page No. - 87)
     10.1 Introduction
     10.2 Europe
             10.2.1 Switzerland
             10.2.2 Germany
             10.2.3 Italy
             10.2.4 France
             10.2.5 UK
             10.2.6 Spain
             10.2.7 Rest of Europe
     10.3 North America
             10.3.1 US
             10.3.2 Canada
     10.4 Asia Pacific
             10.4.1 Japan
             10.4.2 China
             10.4.3 India
             10.4.4 Rest of Asia Pacific
     10.5 Latin America
     10.6 Middle East & Africa

11 Competitive Landscape (Page No. - 144)
     11.1 Overview
     11.2 Competitive Situation and Trends
     11.3 Market Share Analysis

12 Company Profiles (Page No. - 149)
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
     12.1 BASF SE
     12.2 Ashland Global Holdings Inc.
     12.3 DowDuPont Inc.
     12.4 Roquette Freres
     12.5 DFE Pharma
     12.6 JRS Pharma
     12.7 Asahi Kasei Corporation
     12.8 Merck KGaA
     12.9 Corel Pharma Chem
     12.10 Avantor Performance Materials, LLC

*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 173)
     13.1 Insights of Industry Experts
     13.2 Discussion Guide
     13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.4 Available Customizations
     13.5 Related Reports
     13.6 Author Details


List of Tables (124 Tables)

Table 1 Increase in Geriatric Population Across the Globe
Table 2 Drugs Facing Patent Expiry
Table 3 Key Market Drivers: Impact Analysis
Table 4 Key Market Opportunities: Impact Analysis
Table 5 Key Market Challenges: Impact Analysis
Table 6 Superdisintegrants Market, By Type, 2016–2023 (USD Million)
Table 7 Superdisintegrants Market, By Country/Region, 2016–2023 (USD Million)
Table 8 Synthetic Superdisintegrants Market, By Type, 2016–2023 (USD Million)
Table 9 Synthetic Superdisintegrants Market, By Country/Region, 2016–2023 (USD Million)
Table 10 Crospovidone Superdisintegrants Market, By Country/Region, 2016–2023 (USD Million)
Table 11 Modified Starch Superdisintegrants Market, By Country/Region, 2016–2023 (USD Million)
Table 12 Modified Cellulose Superdisintegrants Market, By Type, 2016–2023 (USD Million)
Table 13 Modified Cellulose Superdisintegrants Market, By Country/Region, 2016–2023 (USD Million)
Table 14 Croscarmellose Sodium Superdisintegrants Market, By Country/Region, 2016–2023 (USD Million)
Table 15 Low-Substituted Hydroxypropyl Cellulose Superdisintegrants Market, By Country/Region, 2016–2023 (USD Million)
Table 16 Calcium Silicates Superdisintegrants Market, By Country/Region, 2016–2023 (USD Million)
Table 17 Ion Exchange Resins Superdisintegrants Market, By Country/Region, 2016–2023 (USD Million)
Table 18 Natural Superdisintegrants Market, By Country/Region, 2016–2023 (USD Million)
Table 19 Other Superdisintegrants Market, By Country/Region, 2016–2023 (USD Million)
Table 20 Superdisintegrants Market, By Formulation, 2016–2023 (USD Million)
Table 21 Superdisintegrants Market for Tablets, By Country, 2016–2023 (USD Million)
Table 22 Superdisintegrants Market for Capsules, By Country, 2016–2023 (USD Million)
Table 23 Superdisintegrants Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 24 Superdisintegrants Market for Neurological Diseases, By Country/Region, 2016–2023 (USD Million)
Table 25 Superdisintegrants Market for Gastrointestinal Diseases, By Country/Region, 2016–2023 (USD Million)
Table 26 Superdisintegrants Market for Oncology, By Country/Region, 2016–2023 (USD Million)
Table 27 Superdisintegrants Market for Inflammatory Diseases, By Country/Region, 2016–2023 (USD Million)
Table 28 Superdisintegrants Market for Infectious Diseases, By Country/Region, 2016–2023 (USD Million)
Table 29 Superdisintegrants Market for Cardiovascular Diseases, By Country/Region, 2016–2023 (USD Million)
Table 30 Superdisintegrants Market for Hematological Diseases, By Country/Region, 2016–2023 (USD Million)
Table 31 Superdisintegrants Market, By Region, 2016–2023 (USD Million)
Table 32 Europe: Superdisintegrants Market, By Country, 2016–2023 (USD Million)
Table 33 Europe: Superdisintegrants Market, By Type, 2016–2023 (USD Million)
Table 34 Europe: Synthetic Superdisintegrants Market, By Type, 2016–2023 (USD Million)
Table 35 Europe: Modified Cellulose Market, By Type, 2016–2023 (USD Million)
Table 36 Europe: Superdisintegrants Market, By Formulation, 2016–2023 (USD Million)
Table 37 Europe: Superdisintegrants Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 38 Switzerland: Superdisintegrants Market, By Type, 2016–2023 (USD Million)
Table 39 Switzerland: Synthetic Superdisintegrants Market, By Type, 2016–2023 (USD Million)
Table 40 Switzerland: Modified Cellulose Market, By Type, 2016–2023 (USD Million)
Table 41 Switzerland: Superdisintegrants Market, By Formulation, 2016–2023 (USD Million)
Table 42 Switzerland: Superdisintegrants Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 43 Germany: Superdisintegrants Market, By Type, 2016–2023 (USD Million)
Table 44 Germany: Synthetic Superdisintegrants Market, By Type, 2016–2023 (USD Million)
Table 45 Germany: Modified Cellulose Market, By Type, 2016–2023 (USD Million)
Table 46 Germany: Superdisintegrants Market, By Formulation, 2016–2023 (USD Million)
Table 47 Germany: Superdisintegrants Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 48 Italy: Superdisintegrants Market, By Type, 2016–2023 (USD Million)
Table 49 Italy: Synthetic Superdisintegrants Market, By Type, 2016–2023 (USD Million)
Table 50 Italy: Modified Cellulose Market, By Type, 2016–2023 (USD Million)
Table 51 Italy: Superdisintegrants Market, By Formulation, 2016–2023 (USD Million)
Table 52 Italy: Superdisintegrants Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 53 France: Superdisintegrants Market, By Type, 2016–2023 (USD Million)
Table 54 France: Synthetic Superdisintegrants Market, By Type, 2016–2023 (USD Million)
Table 55 France: Modified Cellulose Market, By Type, 2016–2023 (USD Million)
Table 56 France: Superdisintegrants Market, By Formulation, 2016–2023 (USD Million)
Table 57 France: Superdisintegrants Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 58 UK: Superdisintegrants Market, By Type, 2016–2023 (USD Million)
Table 59 UK: Synthetic Superdisintegrants Market, By Type, 2016–2023 (USD Million)
Table 60 UK: Modified Cellulose Market, By Type, 2016–2023 (USD Million)
Table 61 UK: Superdisintegrants Market, By Formulation, 2016–2023 (USD Million)
Table 62 UK: Superdisintegrants Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 63 Spain: Superdisintegrants Market, By Type, 2016–2023 (USD Million)
Table 64 Spain: Synthetic Superdisintegrants Market, By Type, 2016–2023 (USD Million)
Table 65 Spain: Modified Cellulose Market, By Type, 2016–2023 (USD Million)
Table 66 Spain: Superdisintegrants Market, By Formulation, 2016–2023 (USD Million)
Table 67 Spain: Superdisintegrants Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 68 RoE: Superdisintegrants Market, By Type, 2016–2023 (USD Million)
Table 69 RoE: Synthetic Superdisintegrants Market, By Type, 2016–2023 (USD Million)
Table 70 RoE: Modified Cellulose Market, By Type, 2016–2023 (USD Million)
Table 71 RoE: Superdisintegrants Market, By Formulation, 2016–2023 (USD Million)
Table 72 RoE: Superdisintegrants Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 73 North America: Superdisintegrants Market, By Country, 2016–2023 (USD Million)
Table 74 North America: Superdisintegrants Market, By Type, 2016–2023 (USD Million)
Table 75 North America: Synthetic Superdisintegrants Market, By Type, 2016–2023 (USD Million)
Table 76 North America: Modified Cellulose Market, By Type, 2016–2023 (USD Million)
Table 77 North America: Superdisintegrants Market, By Formulation, 2016–2023 (USD Million)
Table 78 North America: Superdisintegrants Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 79 US: Superdisintegrants Market, By Type, 2016–2023 (USD Million)
Table 80 US: Synthetic Superdisintegrants Market, By Type, 2016–2023 (USD Million)
Table 81 US: Modified Cellulose Market, By Type, 2016–2023 (USD Million)
Table 82 US: Superdisintegrants Market, By Formulation, 2016–2023 (USD Million)
Table 83 US: Superdisintegrants Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 84 Canada: Superdisintegrants Market, By Type, 2016–2023 (USD Million)
Table 85 Canada: Synthetic Superdisintegrants Market, By Type, 2016–2023 (USD Million)
Table 86 Canada: Modified Cellulose Market, By Type, 2016–2023 (USD Million)
Table 87 Canada: Superdisintegrants Market, By Formulation, 2016–2023 (USD Million)
Table 88 Canada: Superdisintegrants Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 89 Asia Pacific: Superdisintegrants Market, By Country, 2016–2023 (USD Million)
Table 90 Asia Pacific: Superdisintegrants Market, By Type, 2016–2023 (USD Million)
Table 91 Asia Pacific: Synthetic Superdisintegrants Market, By Type, 2016–2023 (USD Million)
Table 92 Asia Pacific: Modified Cellulose Market, By Type, 2016–2023 (USD Million)
Table 93 Asia Pacific: Superdisintegrants Market, By Formulation, 2016–2023 (USD Million)
Table 94 Asia Pacific: Superdisintegrants Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 95 Japan: Superdisintegrants Market, By Type, 2016–2023 (USD Million)
Table 96 Japan: Synthetic Superdisintegrants Market, By Type, 2016–2023 (USD Million)
Table 97 Japan: Modified Cellulose Market, By Type, 2016–2023 (USD Million)
Table 98 Japan: Superdisintegrants Market, By Formulation, 2016–2023 (USD Million)
Table 99 Japan: Superdisintegrants Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 100 China: Superdisintegrants Market, By Type, 2016–2023 (USD Million)
Table 101 China: Synthetic Superdisintegrants Market, By Type, 2016–2023 (USD Million)
Table 102 China: Modified Cellulose Market, By Type, 2016–2023 (USD Million)
Table 103 China: Superdisintegrants Market, By Formulation, 2016–2023 (USD Million)
Table 104 China: Superdisintegrants Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 105 India: Superdisintegrants Market, By Type, 2016–2023 (USD Million)
Table 106 India: Synthetic Superdisintegrants Market, By Type, 2016–2023 (USD Million)
Table 107 India: Modified Cellulose Market, By Type, 2016–2023 (USD Million)
Table 108 India: Superdisintegrants Market, By Formulation, 2016–2023 (USD Million)
Table 109 India: Superdisintegrants Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 110 RoAPAC: Superdisintegrants Market, By Type, 2016–2023 (USD Million)
Table 111 RoAPAC: Synthetic Superdisintegrants Market, By Type, 2016–2023 (USD Million)
Table 112 RoAPAC: Modified Cellulose Market, By Type, 2016–2023 (USD Million)
Table 113 RoAPAC: Superdisintegrants Market, By Formulation, 2016–2023 (USD Million)
Table 114 RoAPAC: Superdisintegrants Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 115 Latin America: Superdisintegrants Market, By Type, 2016–2023 (USD Million)
Table 116 Latin America: Synthetic Superdisintegrants Market, By Type, 2016–2023 (USD Million)
Table 117 Latin America: Modified Cellulose Market, By Type, 2016–2023 (USD Million)
Table 118 Latin America: Superdisintegrants Market, By Formulation, 2016–2023 (USD Million)
Table 119 Latin America: Superdisintegrants Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 120 Middle East & Africa: Superdisintegrants Market, By Type, 2016–2023 (USD Million)
Table 121 Middle East & Africa: Synthetic Superdisintegrants Market, By Type, 2016–2023 (USD Million)
Table 122 Middle East & Africa: Modified Cellulose Market, By Type, 2016–2023 (USD Million)
Table 123 Middle East & Africa: Superdisintegrants Market, By Formulation, 2016–2023 (USD Million)
Table 124 Middle East & Africa: Superdisintegrants Market, By Therapeutic Area, 2016–2023 (USD Million)
 
 
List of Figures (37 Figures)
 
Figure 1 Superdisintegrants Market
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designations, and Region
Figure 4 Bottom-Up Approach
Figure 5 Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Superdisintegrants Market, By Product, 2018 vs 2023 (USD Million)
Figure 8 Synthetic Superdisintegrants Market, By Type, 2018 vs 2023 (USD Million)
Figure 9 Superdisintegrants Market, By Formulation, 2018 vs 2023 (USD Million)
Figure 10 Superdisintegrants Market, By Therapeutic Area, 2018 vs 2023 (USD Million)
Figure 11 Geographical Snapshot: Superdisintegrants Market
Figure 12 Increasing Adoption of Orally Disintegrating Tablets is Expected to Drive Market Growth During the Forecast Period
Figure 13 US Dominated the Global Superdisintegrants Market in 2017
Figure 14 APAC to Register the Highest Growth Rate During the Forecast Period (2018–2023)
Figure 15 Crospovidone Accounted for the Largest Share of the Global Superdisintegrants Market in 2017
Figure 16 Developing Markets to Register A Higher Growth Rate Between 2018 & 2023
Figure 17 Superdisintegrants Market: Drivers, Opportunities, and Challenges
Figure 18 Synthetic Superdisintegrants to Dominate the Global Superdisintegrants Market During the Forecast Period
Figure 19 Tablets Segment to Dominate the Superdisintegrants Market During the Forecast Period
Figure 20 Neurological Diseases to Dominate the Superdisintegrants Market During 2018–2023
Figure 21 Cancer Incidence Across Key Countries, 2012
Figure 22 Annual Number of Deaths Due to Infectious Diseases, 2016
Figure 23 Superdisintegrants Market: Geographic Snapshot (2017)
Figure 24 Europe: Pharmaceutical Production, 2015 (USD Million)
Figure 25 Europe: Generics Market (2014)
Figure 26 Europe: Superdisintegrants Market Snapshot
Figure 27 North America: Superdisintegrants Market Snapshot
Figure 28 Asia Pacific: Superdisintegrants Market Snapshot
Figure 29 Key Developments in the Superdisintegrants Market From 2015 to May 2018
Figure 30 Superdisintegrants Market Share, By Key Player, 2017
Figure 31 BASF SE: Company Snapshot (2017)
Figure 32 Ashland Global Holdings Inc.: Company Snapshot (2017)
Figure 33 Dowdupont Inc.: Company Snapshot (2017)
Figure 34 Roquette Freres: Company Snapshot (2017)
Figure 35 Asahi Kasei Corporation: Company Snapshot (2017)
Figure 36 Merck KGaA: Company Snapshot (2017)
Figure 37 Marketsandmarkets Knowledge Store: Healthcare Industry Snapshot


Request for detailed methodology, assumptions & how numbers were triangulated.

Please share your problem/objectives in greater details so that our analyst can verify if they can solve your problem(s).
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
PH 4350
Published ON
Aug, 2018
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Superdisintegrants Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved